<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>short-chain fatty acids &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/short-chain-fatty-acids/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 14 Jan 2026 17:27:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>short-chain fatty acids &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exploring Gut Microbiota’s Role in Prostate Health</title>
		<link>https://bioengineer.org/exploring-gut-microbiotas-role-in-prostate-health/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 17:27:39 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Benign Prostatic Hyperplasia]]></category>
		<category><![CDATA[dietary interventions]]></category>
		<category><![CDATA[gut microbiota]]></category>
		<category><![CDATA[network pharmacology]]></category>
		<category><![CDATA[short-chain fatty acids]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-gut-microbiotas-role-in-prostate-health/</guid>

					<description><![CDATA[In a groundbreaking study published in the esteemed BMC Pharmacology and Toxicology, researchers Xu, Y., An, L., and Xie, J. have embarked on an innovative exploration regarding the gut microbiota and its metabolites’ influence on benign prostatic hyperplasia (BPH). This common condition affects a significant portion of the aging male population, characterized by an enlargement [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316905</post-id>	</item>
		<item>
		<title>Enhancing Gut Microbiota: RS2 and Arabinoxylan in PCOS</title>
		<link>https://bioengineer.org/enhancing-gut-microbiota-rs2-and-arabinoxylan-in-pcos/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 24 Nov 2025 22:04:42 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Dietary fibers]]></category>
		<category><![CDATA[gut microbiota]]></category>
		<category><![CDATA[insulin resistance]]></category>
		<category><![CDATA[PCOS]]></category>
		<category><![CDATA[short-chain fatty acids]]></category>
		<guid isPermaLink="false">https://bioengineer.org/enhancing-gut-microbiota-rs2-and-arabinoxylan-in-pcos/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Endocrine Disorders, Liang et al. delve deep into the complex interplay between gut microbiota and polycystic ovary syndrome (PCOS). The research focuses on how resistant starch type 2 (RS2) and arabinoxylan, a type of hemicellulose, can induce significant improvements in PCOS phenotypes through their effects on gut microbiota [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300766</post-id>	</item>
		<item>
		<title>Gut Microbiota Imbalance in Polycystic Ovary Syndrome</title>
		<link>https://bioengineer.org/gut-microbiota-imbalance-in-polycystic-ovary-syndrome/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 10 Nov 2025 16:00:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bağırsak mikrobiyotası dengesizliği]]></category>
		<category><![CDATA[Balgam-nem PCOS]]></category>
		<category><![CDATA[Disbiyoz tedavisi]]></category>
		<category><![CDATA[gut microbiota dysbiosis]]></category>
		<category><![CDATA[Kısa zincirli yağ asitleri]]></category>
		<category><![CDATA[PCOS Microbiome Research]]></category>
		<category><![CDATA[Phlegm-Dampness PCOS]]></category>
		<category><![CDATA[Polikistik Over Sendromu]]></category>
		<category><![CDATA[Polycystic ovary syndrome]]></category>
		<category><![CDATA[short-chain fatty acids]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gut-microbiota-imbalance-in-polycystic-ovary-syndrome/</guid>

					<description><![CDATA[In recent years, the intricate relationship between the gut microbiota and various metabolic and hormonal disorders has captured the attention of researchers worldwide. Among these disorders, Polycystic Ovary Syndrome (PCOS) stands out due to its prevalence and impact on women’s health. A groundbreaking study led by Xia et al. has uncovered compelling evidence linking gut [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">294139</post-id>	</item>
		<item>
		<title>Link Between Gut Microbiota and MASLD Revealed</title>
		<link>https://bioengineer.org/link-between-gut-microbiota-and-masld-revealed/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 12 Oct 2025 12:23:56 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[dysbiosis]]></category>
		<category><![CDATA[gut microbiota]]></category>
		<category><![CDATA[MASLD]]></category>
		<category><![CDATA[metabolic dysfunction]]></category>
		<category><![CDATA[short-chain fatty acids]]></category>
		<guid isPermaLink="false">https://bioengineer.org/link-between-gut-microbiota-and-masld-revealed/</guid>

					<description><![CDATA[The human gut microbiota is an intricate ecosystem of trillions of microorganisms living within our intestines, which play a critical role in maintaining our metabolic processes. Recent research has begun to uncover the profound impact that these microbes have on various health conditions, one of which is metabolic dysfunction-associated steatotic liver disease (MASLD). This condition, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">279541</post-id>	</item>
	</channel>
</rss>
